Detalles de la búsqueda
1.
Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis.
Pediatr Nephrol
; 36(7): 1765-1774, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33635379
2.
Correction to: Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments.
Pediatr Nephrol
; 36(1): 215, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32989611
3.
Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments.
Pediatr Nephrol
; 36(1): 83-91, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32712761
4.
Bone mineral density and growth changes in patients with distal renal tubular acidosis after two-years treatment with a new alkalizing drug (ADV7103).
Nefrologia (Engl Ed)
; 43(4): 458-466, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36529656
5.
An innovative ethosuximide granule formulation designed for pediatric use: Comparative pharmacokinetics, safety, tolerability, and palatability profile versus reference syrup.
Pharmacol Res Perspect
; 11(1): e01032, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36537292
6.
Lived experiences of patients with distal renal tubular acidosis treated with ADV7103 and of their caregivers: a qualitative study.
Orphanet J Rare Dis
; 17(1): 141, 2022 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35346296
7.
Bone mineral density and growth changes in patients with distal renal tubular acidosis after two-years treatment with a new alkalizing drug (ADV7103) / Cambios en la densidad mineral ósea y en el crecimiento en pacientes con acidosis tubular renal distal tras dos años de tratamiento con un nuevo fármaco alcalinizante (ADV7103)
Nefrología (Madrid)
; 43(4): 458-466, jul.-ago. 2023. tab, graf
Artículo
en Inglés
| IBECS (España) | ID: ibc-223965
8.
Improved growth of a child with primary distal renal tubular acidosis after switching from a conventional alkalizing treatment to a new prolonged-release formulation containing potassium citrate and potassium bicarbonate: lessons for the clinical nephrologist.
J Nephrol
; 35(8): 2119-2122, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35357683
Resultados
1 -
8
de 8
1
Próxima >
>>